British Association of Dermatologists and British Photodermatology Group Guidelines for the Safe and Effective Use of Psoralen–Ultraviolet A Therapy 2015

T.C. Ling; T.H. Clayton; J. Crawley; L.S. Exton; V. Goulden; S. Ibbotson; K. McKenna; M.F. Mohd Mustapa; L.E. Rhodes; R. Sarkany; R.S. Dawe


The British Journal of Dermatology. 2016;174(1):24-55. 

In This Article

Future Directions

We have presented updated evidence to assist in the safe and effective use of PUVA therapy, although gaps still remain in direct evidence of comparison. Suggested areas for future research include: (i) a randomized comparative study comparing PUVA with biological therapy for chronic plaque psoriasis – this would help with guidance on whether to prescribe PUVA before biological therapies, taking into consideration the RR and efficacy; (ii) a study to investigate whether or not there is an effect of MPD measurement at 72 and 96 h on erythemal episodes during PUVA and efficacy outcome measures.